COL1A2 and cancer: We have successfully constructed a reverse mRNA prediction model based on LINC00638/hsa-miR-552-3p/COL1A2 ceRNA network as the upstream regulatory mechanism of COL1A2, which advances our understanding of the pathogenesis of this very common tumor and paves the way for further cancer therapeutics.